Repatha cuts cardio events, but not mortality.
Decision paves way for cheaper competitor in autumn 2018.
Analysis questions industry’s rationale for high US prices.
Biosimilars firm facing court battle.
Viral Safety conference
Mylan and Biocon file biosimilar of white blood cell booster
Sales of Praluent can continue during patent case appeal.
Trump calls pharma leaders to White House to discuss cutting taxes, regulations – and drug prices